Gui-Dong Zhu

USPTO Granted Patents = 24 (Patent Applications = 3)

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 7 (Patent Applications = 3)

Average Co-Inventor Count = 5.4

ph-index = 7

Forward Citations = 514(Granted Patents)

Company Filing History:

15 out of 4,177

Abbott Laboratories Corporation

1 out of 832,680

Other

patents

Years Active: 2001-2016

Loading Chart...

24 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9328112 - Tetracyclic CDK9 kinase inhibitors (2016-05-03),

2. 9283222 - Inhibitors of poly(ADP-ribose)polymerase (2016-03-15),

3. 9051327 - Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases (2015-06-09),

4. 8796289 - Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases (2014-08-05),

5. 8697736 - 1H-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent PARP inhibitors (2014-04-15),

6. 8546368 - Pyrazoloquinolones are potent PARP inhibitors (2013-10-01),

7. 8466150 - Inhibitors of poly(ADP-ribose)polymerase (2013-06-18),

8. 8450320 - Pyrrolopyrazinone inhibitors of kinases (2013-05-28),

9. 8435980 - Pyrrolopyridine inhibitors of kinases (2013-05-07),

10. 8383624 - Pyrrolopyrazine inhibitors of kinases (2013-02-26),

11. 8383623 - Phthalazin-(2H)-one inhibitors of kinases (2013-02-26),

12. 8217070 - 2-substituted-1H-benzimidazole-4-carboxamides are PARP inhibitors (2012-07-10),

13. 8143284 - Poly(ADP-ribose)polymerase inhibitors (2012-03-27),

14. 8067613 - Benzimidazole poly(ADP ribose)polymerase inhibitors (2011-11-29),

15. 8013168 - 2-{(R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 2 (2011-09-06),

Title: Innovator Spotlight: Gui-Dong Zhu – A Pioneer in Cancer Treatment

Introduction: Gui-Dong Zhu, based in Gurnee, IL, is a prominent inventor in the pharmaceutical industry, holding an impressive portfolio of 24 patents. His innovative contributions primarily focus on developing novel compounds and therapeutic agents used in the treatment of serious diseases, including cancer. Zhu's work exemplifies the intersection of research and technological advancement in the pursuit of better health outcomes.

Latest Patents: Among Zhu's latest innovations are significant patents that showcase his expertise in pharmaceutical chemistry. One notable patent is for Tetracyclic CDK9 kinase inhibitors, which discloses compounds capable of treating various forms of cancer through the inhibition of crucial cellular processes. Additionally, he has developed inhibitors of poly(ADP-ribose) polymerase, detailing methods for their production and application in therapeutic settings. These advancements reflect Zhu's commitment to pushing the boundaries of medical science.

Career Highlights: Throughout his career, Gui-Dong Zhu has worked for well-respected organizations, including Abbott Laboratories and Abbvie Inc. His roles in these companies have allowed him to contribute significantly to drug development and research initiatives. Zhu's focus on innovative therapeutic solutions has not only enhanced his professional stature but also served the broader community.

Collaborations: Zhu has collaborated with esteemed colleagues in the research arena, including Thomas Dale Penning and Virajkumar B Gandhi. These partnerships have fostered a collaborative environment focused on overcoming challenging biomedical issues, enabling the exchange of ideas and enhancing the scope of their work.

Conclusion: Gui-Dong Zhu stands out as a leading inventor whose research has made substantial impacts on cancer treatment through innovative patent developments. With a robust portfolio and collaborative efforts, his work continues to pave the way for advancements in the pharmaceutical field, emphasizing the importance of innovation in addressing pressing health challenges.

This text is generated by artificial intelligence and may not be accurate.